Sporadic and hereditary CRCs have different mechanisms of MMR inactivation, that mostly consist in point mutations of the hMLH1 or hMSH2 genes in the case of hereditary CRC, and in promoter hyper-methylation of the hMLH1 gene in sporadic CRC [29]. This evidence concerns the gene MLH1 and colorectal carcinoma.